Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Cardiac Sciences
    • High BP during...

    High BP during pregnancy increases later CVD risk by more than 70%: JAMA

    Written by Deepanjana Sarkar Published On 2019-06-16T20:20:07+05:30  |  Updated On 16 Jun 2019 8:20 PM IST
    High BP during pregnancy increases later CVD risk by more than 70%: JAMA

    High Blood pressure, BP during pregnancy increases later CVD risk by more than 70%, finds a JAMA study.


    High Blood pressure, BP and Body Mass Index, BMI during pregnancy are linked to a 77% increased risk of cardiovascular disease in women in later life. Therefore a history of hypertensive disorders of pregnancy, HDP calls for more aggressive follow-up in all such women for the development of cardiovascular disorders. The study has appeared in the JAMA Cardiology.


    The study aimed at evaluating the risk of cardiovascular disease in the presence of conventional cardiovascular risk factors in pregnant women.


    The authors conducted a prospective cohort study with an average follow-up of 18 years. A population-based cohort of women participating in the Nord-Trøndelag Health Study in Norway. They linked data for 31 364 women from the Nord-Trøndelag Health Study (1984-2008) to validated hospital records (1987-2015), the Cause of Death Registry (1984-2015), and the Medical Birth Registry of Norway (1967-2012). A total of 7399 women were excluded based on selected pregnancy characteristics, incomplete data, or because of emigrating or experiencing the endpoint before the start of follow-up, leaving 23 885 women for the study. Data were analyzed between January 1, 2018, and June 6, 2018. The selected criteria were: women experiencing 1 or more pregnancies complicated by hypertensive disorders of pregnancy, HDP before age 40 years vs only experiencing normotensive pregnancies.


    The authors have used Cox proportional hazards models to estimate the hazard ratios (HRs) for the association between hypertensive disorders of pregnancy, HDP and CVD. The proportion of excess risk associated with conventional cardiovascular risk factors was estimated using an inverse odds ratio weighting approach.


    Main findings of the study




    • The study population consisted of 23 885 parous women from Nord-Trøndelag County, Norway.

    • The study population consisted of 23 885 parous women from Nord-Trøndelag County, Norway.

    • A total of 21 766 women had only normotensive pregnancies i.e normal blood pressure during pregnancy, while 2199 women experienced ever having an HDP.

    • From age 40 to 70 years, women with a history of HDP i.e, abnormal blood pressure during pregnancy, had an increased risk of CVD compared with women with only normotensive pregnancies.

    • Blood pressure and body mass index were associated with up to 77% of the excess risk of CVD in women with a history of HDP, while glucose and lipid levels were associated with smaller proportions.


    The authors concluded that the risk of excess CVD in women with a history of pregnancy, HDP was associated with conventional cardiovascular risk factors, indicating that these risk factors are important targets for cardiovascular prevention in these women.


    For further reference, click on the link


    doi:10.1001/jamacardio.2019.1746

    blood pressureBMIbody mass indexBPCardiologycardiovascularcardiovascular diseaseCardiovascular RiskcohortCVDhypertensive disorderhypertensive disorders of pregnancyJAMANord-Trøndelag Health Studynormotensive pregnanciesNorwayPregnancypregnancy characteristicrisk factors

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Deepanjana Sarkar
    Deepanjana Sarkar
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok